Method of Screening Antibacterial Drug Compounds
AssigneeTemasek Lifesciences Laboratory
InventorsRamanujam Srinivasan, Mohan Balasubramanian, Maki Hori
Life of this patent
Estimating the term…
Loading patent…
AssigneeTemasek Lifesciences Laboratory
InventorsRamanujam Srinivasan, Mohan Balasubramanian, Maki Hori
Estimating the term…
Compounds are identified simultaneously as having antibiotic activity targeting a specific microbial protein and having no or limited toxicity against eukaryotic cells by expressing the microbial protein in eukaryotic cells by expressing the microbial protein in eukaryotic cells which then are used to screen candidate antibiotic compounds. Preferably, yeast cells such as Schizosaccharomyces pombe are transfected with and express a target bacterial protein such as FtsZ or MreB, optionally as a fusion with a reporter protein, and these transfected cells are used to screen libraries of compounds simultaneously for activity against the bacterial protein and lack of toxicity against the yeast cell.
An in vitro method for identifying antibacterial compounds that have significantly greater toxicity to a specific bacterial protein than to eukaryotic cells, which comprises:
An antibiotic screening cell culture which comprises an in vitro culture of Schizosaccharomyces pombe that expresses a bacterial target protein selected from the group consisting of FtsZ, MreB, both FtsZ and MreB, and fusions thereof with a reporter protein.
A method of identifying antibacterial target proteins from bacteria, which comprises:
Dependencies are inferred from the claim text.